Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06152224 · ClinicalTrials.gov registry record · Phase 4

Use of the LEVA® Pelvic Health System for Fecal Incontinence

A Phase 4 study of Fecal Incontinence, sponsored by University of Wisconsin, Madison.

Active
Registry status
Phase 4
Development phase
38
Enrollment target
1
Study location

NCT06152224 is a Phase 4 study of Fecal Incontinence that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 38 participants, below the 333-participant average among 22 other Fecal Incontinence trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06152224, a Phase 4 study of Fecal Incontinence, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn about how the duration of use of The Leva Pelvic Health System® affects treatment of fecal incontinence in women. The main question it aims to answer is to test whether use of the The Leva Pelvic Health System® for 8 weeks is as good as using it for 16 weeks. Participants will complete surveys, and use the Leva device.

Conditions Studied

Interventions

  • DEVICE The Leva Pelvic Health System

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2024-01-17
Est. Completion 2026-09
Phase Phase 4

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT06152224

The ClinicalTrials.gov registry entry for NCT06152224 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 333-participant average among 22 other Fecal Incontinence trials with a reported enrollment target (89% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fecal Incontinence appearing as the primary indexed condition, and to 1 intervention - of which The Leva Pelvic Health System is the first listed.

NCT06152224 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06152224 about?

NCT06152224 is a clinical study titled "Use of the LEVA® Pelvic Health System for Fecal Incontinence". The goal of this clinical trial is to learn about how the duration of use of The Leva Pelvic Health System® affects treatment of fecal incontinence in women. The main question it aims to answer is to test whether use of the The Leva Pelvic Health System® for 8 weeks is as good as using it for 16 wee...

What is the current status of trial NCT06152224?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2024-01-17. Estimated completion is 2026-09.

What conditions does trial NCT06152224 study?

This clinical trial studies the following conditions: Fecal Incontinence.

What interventions are being tested in trial NCT06152224?

The interventions under investigation include: The Leva Pelvic Health System (DEVICE).

Who is sponsoring clinical trial NCT06152224?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06152224 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fecal Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.